BioneerCorp
KOSDAQ:064550
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Medicskin Holdings Ltd
HKEX:8307
|
HK |
|
N
|
Nutrien Ltd
NYSE:NTR
|
CA |
BioneerCorp
Total Equity
BioneerCorp
Total Equity Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
B
|
BioneerCorp
KOSDAQ:064550
|
Total Equity
₩209.7B
|
CAGR 3-Years
-4%
|
CAGR 5-Years
8%
|
CAGR 10-Years
20%
|
|
|
Celltrion Inc
KRX:068270
|
Total Equity
₩17.2T
|
CAGR 3-Years
61%
|
CAGR 5-Years
39%
|
CAGR 10-Years
27%
|
|
|
O
|
OliX Pharmaceuticals Inc
KOSDAQ:226950
|
Total Equity
₩149.4B
|
CAGR 3-Years
31%
|
CAGR 5-Years
27%
|
CAGR 10-Years
N/A
|
|
|
V
|
Voronoi Inc
KOSDAQ:310210
|
Total Equity
₩66.4B
|
CAGR 3-Years
113%
|
CAGR 5-Years
37%
|
CAGR 10-Years
N/A
|
|
|
Alteogen Inc
KOSDAQ:196170
|
Total Equity
₩445.2B
|
CAGR 3-Years
44%
|
CAGR 5-Years
28%
|
CAGR 10-Years
28%
|
|
|
A
|
ABL Bio Inc
KOSDAQ:298380
|
Total Equity
₩154.7B
|
CAGR 3-Years
31%
|
CAGR 5-Years
11%
|
CAGR 10-Years
N/A
|
|
BioneerCorp
Glance View
BIONEER Corp. engages in the manufacture and sale of biotechnological products. The company is headquartered in Daejeon, Daejeon. The company went IPO on 2005-12-29. The firm mainly focuses on the development of deoxyribonucleic acid (DNA) reagents, molecular diagnostic kits and other services, such as DNA and ribonucleic acid (RNA) amplification products, Oligo synthesis and reagents, gene synthesis services, gene expressions, protein expressions and purifications, genomics services, human diagnostics kits, veterinary diagnostics kits and others. The company also provides DNA devices, including DNA extraction, amplification and quantitative analysis devices and other DNA diagnostic devices, and supplies for tests and others. In addition, it provides equipment and supplies used for biotechnology research. The firm operates its business within domestic market and in overseas markets, including America, China, Japan, India, Africa and others.
See Also
What is BioneerCorp's Total Equity?
Total Equity
209.7B
KRW
Based on the financial report for Dec 31, 2025, BioneerCorp's Total Equity amounts to 209.7B KRW.
What is BioneerCorp's Total Equity growth rate?
Total Equity CAGR 10Y
20%
Over the last year, the Total Equity growth was -2%. The average annual Total Equity growth rates for BioneerCorp have been -4% over the past three years , 8% over the past five years , and 20% over the past ten years .
